Effect of probiotic bacteria on microbial host defense, growth and immune function in human immunodeficiency virus type-1 infection

Nutrients

Volumn 3, Issue 12, 2011, Pages 1042-1070

  Cunningham Rundles, Susanna ^a   Ahrné, Siv ^b   Johann Liang, Rosemary ^a,d   Abuav, Rachel ^a,e   Dunn Navarra, Ann Margaret ^a,f   Grassey, Claudia ^a   Bengmark, Stig ^c   Cervia, Joseph S ^a,g  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Department of Health and Human Services   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aids; Anti retroviral therapy; Anti retroviral therapy (art) 10.3390 nu3121042; Bcm; Body cellular mass; Body mass index (bmi); Children; Failure to thrive; Growth; Gut associated lymphoid tissue (galt); Hiv 1; Immune development; Inflammation; Lactobacillus; Microbial translocation; Microflora; Micronutrient; Mucosal barrier; Nutrition; Probiotic bacteria; Women

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD14 ANTIGEN; ESTRIOL; LIPOPOLYSACCHARIDE; METRONIDAZOLE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SELENIUM; TOLL LIKE RECEPTOR 4; VITAMIN D; YOGHURT; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ARTIFICIAL MILK; AUTOIMMUNITY; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM ANIMALIS; BODY MASS; CELL LINEAGE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; ENTERITIS; FAILURE TO THRIVE; FLATULENCE; GROWTH DISORDER; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MEMBRANE RECONSTITUTION; MICROFLORA; MORBIDITY; MORTALITY; NAUSEA; NONHUMAN; NUTRITIONAL STATUS; REGULATORY T LYMPHOCYTE; RISK REDUCTION; STOMACH PROTECTION; TH17 CELL; TREATMENT RESPONSE; VAGINITIS;

EID: 84455208831     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu3121042     Document Type: Article

References (143)

1. Bengmark, S.; Jeppsson, B. Gastrointestinal surface protection and mucosa reconditioning. JPEN J. Parenter. Enteral. Nutr. 1995, 19, 410-415.
2. Dicks, L.M.; Fraser, T.; ten Doeschate, K.; van Reenen, C.A. Lactic acid bacteria population in children diagnosed with human immunodeficiency virus. J. Paediatr. Child Health 2009, 45, 567-572.
3. Dwyer, J.T. Nutrition support of HIV+ patients. Henry Ford Hosp. Med. J. 1991, 39, 60-65.
4. Kaufman, F.R.; Gomperts, E.D. Growth failure in boys with hemophilia and HIV infection. Am. J. Pediatr. Hematol. Oncol. 1989, 11, 292-294.
5. Kotler, D.P. Wasting syndrome: Nutritional support in HIV infection. AIDS Res. Hum. Retrovir. 1994, 10, 931-934.
6. Shannon, K.M.; Ammann, A.J. Acquired immune deficiency syndrome in childhood. J. Pediatr. 1985, 106, 332-342.
7. Cunningham-Rundles, S.; Ahrne, S.; Bengmark, S.; Johann-Liang, R.; Marshall, F.; Metakis, L.; Califano, C.; Dunn, A.M.; Grassey, C.; Hinds, G.; et al. Probiotics and immune response. Am. J. Gastroenterol. 2000, 95, S22-S25.
8. Cunningham-Rundles, S.; Lin, D.H. Nutrition and the immune system of the gut. Nutrition 1998, 14, 573-579.
9. Fergusson, P.; Tomkins, A. HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: A systematic review and meta-analysis. Trans. R. Soc. Trop. Med. Hyg. 2009, 103, 541-548.
10. Cunningham-Rundles, S.; McNeeley, D.F.; Moon, A. Mechanisms of nutrient modulation of the immune response. J. Allergy Clin. Immunol. 2005, 115, 1119-1128; quiz 1129.
11. Noyer, C.M.; Simon, D.; Borczuk, A.; Brandt, L.J.; Lee, M.J.; Nehra, V. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am. J. Gastroenterol. 1998, 93, 972-975.
12. Bushen, O.Y.; Davenport, J.A.; Lima, A.B.; Piscitelli, S.C.; Uzgiris, A.J.; Silva, T.M.; Leite, R.; Kosek, M.; Dillingham, R.A.; Girao, A. et al. Diarrhea and reduced levels of antiretroviral drugs: Improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin. Infect. Dis. 2004, 38, 1764-1770.
13. Kotler, D.P. Nutritional effects and support in the patient with acquired immunodeficiency syndrome. J. Nutr. 1992, 122, 723-727.
14. Irlam, J.H.; Visser, M.M.; Rollins, N.N.; Siegfried, N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst. Rev. 2010, 12, doi:10.1002/14651858. CD003650.pub2.
15. Fawzi, W.; Msamanga, G.; Spiegelman, D.; Hunter, D.J. Studies of vitamins and minerals and HIV transmission and disease progression. J. Nutr. 2005, 135, 938-944.
16. Koethe, J.R.; Lukusa, A.; Giganti, M.J.; Chi, B.H.; Nyirenda, C.K.; Limbada, M.I.; Banda, Y.; Stringer, J.S. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J. Acquir. Immune Defic. Syndr. 2010, 53, 507-513.
17. Winter, H.S.; Oleske, J.M.; Hughes, M.D.; McKinney, R.E., Jr.; Elgie, C.; Powell, C.; Purdue, L.; Puga, A.M.; Jimenez, E.; Scott, G.B.et al. Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 222-232.
18. Luoto, R.; Kalliomaki, M.; Laitinen, K.; Delzenne, N.M.; Cani, P.D.; Salminen, S.; Isolauri, E. Initial dietary and microbiological environments deviate in normal-weight compared to overweight children at 10 years of age. J. Pediatr. Gastroenterol. Nutr. 2011, 52, 90-95.
19. Backhed, F. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: The normal gut microbiota in health and disease. Clin. Exp. Immunol. 2010, 160, 80-84.
20. Gori, A.; Tincati, C.; Rizzardini, G.; Torti, C.; Quirino, T.; Haarman, M.; Ben Amor, K.; van Schaik, J.; Vriesema, A.; Knol, J.et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol. 2008, 46, 757-758.
21. Hummelen, R.; Fernandes, A.D.; Macklaim, J.M.; Dickson, R.J.; Changalucha, J.; Gloor, G.B.; Reid, G. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010, 5, doi:10.1371/journal.pone.0012078.
22. Spear, G.T.; Sikaroodi, M.; Zariffard, M.R.; Landay, A.L.; French, A.L.; Gillevet, P.M. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J. Infect. Dis. 2008, 198, 1131-1140.
23. Hummelen, R.; Changalucha, J.; Butamanya, N.L.; Cook, A.; Habbema, J.D.; Reid, G. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int. J. Gynaecol. Obstet. 2010, 111, 245-248.
24. Gori, A.; Rizzardini, G.; Van't Land, B.; Amor, K.B.; van Schaik, J.; Torti, C.; Quirino, T.; Tincati, C.; Bandera, A.; Knol, J.; et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "COPA" pilot randomized trial. Mucosal Immunol. 2011, 4, 554-563.
25. Peoples, J.D.; Cheung, S.; Nesin, M.; Lin, H.; Tatad, A.M.; Hoang, D.; Perlman, J.M.; Cunningham-Rundles, S. Neonatal cord blood subsets and cytokine response to bacterial antigens. Am. J. Perinatol. 2009, 26, 647-657.
26. Stencel-Gabriel, K.; Gabriel, I.; Wiczkowski, A.; Paul, M.; Olejek, A. Prenatal priming of cord blood T lymphocytes by microbiota in the maternal vagina. Am. J. Reprod. Immunol. 2009, 61, 246-252.
27. Karlsson, H.; Hessle, C.; Rudin, A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 2002, 70, 6688-6696.
28. Tatad, A.M.; Nesin, M.; Peoples, J.; Cheung, S.; Lin, H.; Sison, C.; Perlman, J.; Cunningham-Rundles, S. Cytokine Expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology 2007, 94, 8-15.
29. Fak, F.; Ahrne, S.; Molin, G.; Jeppsson, B.; Westrom, B. Microbial manipulation of he rat dam changes bacterial colonization and alters properties of the gut in her offspring. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G148-G154.
30. Serwadda, D.; Mugerwa, R.D.; Sewankambo, N.K.; Lwegaba, A.; Carswell, J.W.; Kirya, G.B.; Bayley, A.C.; Downing, R.G.; Tedder, R.S.; Clayden, S.A.; et al. Slim disease: A new disease in Uganda and its association with HTLV-III infection. Lancet 1985, 2, 849-852.
31. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb. Mortal. Wkly. Rep. 1987, 36 (Suppl. 1), 1S-15S.
32. Kotler, D.P.; Tierney, A.R.; Wang, J.; Pierson, R.N., Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am. J. Clin. Nutr. 1989, 50, 444-447.
33. Kotler, D.P.; Reka, S.; Clayton, F. Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig. Dis. Sci. 1993, 38, 1119-1127.
34. Pantaleo, G.; Graziosi, C.; Demarest, J.F.; Butini, L.; Montroni, M.; Fox, C.H.; Orenstein, J.M.; Kotler, D.P.; Fauci, A.S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362, 355-358.
35. Wanke, C. Pathogenesis and Consequences of HIV-Associated Wasting. J. Acquir. Immune Defic. Syndr. 2004, 37 (Suppl. 5), S277-S279.
36. Moldawer, L.L.; Sattler, F.R. Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation. Semin. Oncol. 1998, 25, 73-81.
37. Batterham, M.J. Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: A meta-analysis. Am. J. Clin. Nutr. 2005, 81, 702-713.
38. De Pee, S.; Semba, R.D. Role of nutrition in HIV infection: Review of evidence for more effective programming in resource-limited settings. Food Nutr. Bull. 2010, 31, S313-S344.
39. Kotler, D.; Wanke, C. Management of HIV wasting syndrome: A consensus conference. J. Acquir. Immune Defic. Syndr. 2004, 37, S261-S288.
40. Crenn, P.; Rakotoanbinina, B.; Raynaud, J.J.; Thuillier, F.; Messing, B.; Melchior, J.C. Hyperphagia contributes to the normal body composition and protein-energy balance in HIV-infected asymptomatic men. J. Nutr. 2004, 134, 2301-2306.
41. Crenn, P.; de Truchis, P.; Neveux, N.; Galperine, T.; Cynober, L.; Melchior, J.C. Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients. Am. J. Clin. Nutr. 2009, 90, 587-594.
42. Ndekha, M.; van Oosterhout, J.J.; Saloojee, H.; Pettifor, J.; Manary, M. Nutritional status of Malawian adults on antiretroviral therapy 1 year after supplementary feeding in the first 3 months of therapy. Trop. Med. Int. Health 2009, 14, 1059-1063.
43. Falutz, J.; Tsoukas, C.; Cardno, T. Serum zinc in homosexual men. Clin. Chem. 1989, 35, 704-705.
44. Dworkin, B.M. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem. Biol. Interact. 1994, 91, 181-186.
45. Harriman, G.R.; Smith, P.D.; Horne, M.K.; Fox, C.H.; Koenig, S.; Lack, E.E.; Lane, H.C.; Fauci, A.S. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 1989, 149, 2039-2041.
46. Mburu, A.S.; Thurnham, D.I.; Mwaniki, D.L.; Muniu, E.M.; Alumasa, F.M. The influence of inflammation on plasma zinc concentration in apparently healthy, HIV+ Kenyan adults and zinc responses after a multi-micronutrient supplement. Eur. J. Clin. Nutr. 2010, 64, 510-517.
47. Tang, A.M.; Graham, N.M.; Semba, R.D.; Saah, A.J. Association between serum vitamin A and E levels and HIV-1 disease progression. Aids 1997, 11, 613-620.
48. Tang, A.M.; Graham, N.M.; Chandra, R.K.; Saah, A.J. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J. Nutr. 1997, 127, 345-351.
49. Forrester, J.E.; Wang, X.D.; Knox, T.A.; Borek, C.G.; Tang, A.M.; Johnson, E.J. Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use. J. Public Health Policy 2009, 30, 285-299.
50. Jones, C.Y.; Tang, A.M.; Forrester, J.E.; Huang, J.; Hendricks, K.M.; Knox, T.A.; Spiegelman, D.; Semba, R.D.; Woods, M.N. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J. Acquir. Immune Defic. Syndr. 2006, 43, 475-482.
51. Baum, M.K.; Lai, S.; Sales, S.; Page, J.B.; Campa, A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin. Infect. Dis. 2010, 50, 1653-1660.
52. Dao, C.N.; Patel, P.; Overton, E.T.; Rhame, F.; Pals, S.L.; Johnson, C.; Bush, T.; Brooks, J.T. Low vitamin D among HIV-infected adults: Prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin. Infect. Dis. 2011, 52, 396-405.
53. Torres, C.; Sanchez de la Torre, M.; Garcia-Moruja, C.; Carrero, A.J.; Trujillo Mdel, M.; Fibla, J.; Caruz, A. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Curr. HIV Res. 2010, 8, 487-492.
54. Hendricks, K.M.; Mwamburi, D.M.; Newby, P.K.; Wanke, C.A. Dietary patterns and health and nutrition outcomes in men living with HIV infection. Am. J. Clin. Nutr. 2008, 88, 1584-1592.
55. Woods, M.N.; Tang, A.M.; Forrester, J.; Jones, C.; Hendricks, K.; Ding, B.; Knox, T.A. Effect of dietary intake and protease inhibitors on serum vitamin B12 levels in a cohort of human immunodeficiency virus-positive patients. Clin. Infect. Dis. 2003, 37 (Suppl. 2), S124-S131.
56. Stone, C.A.; Kawai, K.; Kupka, R.; Fawzi, W.W. Role of selenium in HIV infection. Nutr. Rev. 2010, 68, 671-681.
57. Hurwitz, B.E.; Klaus, J.R.; Llabre, M.M.; Gonzalez, A.; Lawrence, P.J.; Maher, K.J.; Greeson, J.M.; Baum, M.K.; Shor-Posner, G.; Skyler, J.S.; Schneiderman, N. uppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch. Intern. Med. 2007, 167, 148-154.
58. Sankaran, S.; Guadalupe, M.; Reay, E.; George, M.D.; Flamm, J.; Prindiville, T.; Dandekar, S. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 2005, 102, 9860-9865.
59. Stone, J.D.; Heise, C.C.; Miller, C.J.; Halsted, C.H.; Dandekar, S. Development of malabsorption and nutritional complications in simian immunodeficiency virus-infected rhesus macaques. Aids 1994, 8, 1245-1256.
60. Stein, T.P.; Koerner, B.; Schluter, M.D.; Leskiw, M.J.; Gaprindachvilli, T.; Richards, E.W.; Cope, F.O.; Condolucci, D. Weight loss, the gut and the inflammatory response in aids patients. Cytokine 1997, 9, 143-147.
61. Lane, H.C.; Masur, H.; Edgar, L.C.; Whalen, G.; Rook, A.H.; Fauci, A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983, 309, 453-458.
62. Giorgi, J.V.; Hultin, L.E.; McKeating, J.A.; Johnson, T.D.; Owens, B.; Jacobson, L.P.; Shih, R.; Lewis, J.; Wiley, D.J.; Phair, J.P.; et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 1999, 179, 859-870.
63. Grossman, Z.; Meier-Schellersheim, M.; Paul, W.E.; Picker, L.J. Pathogenesis of HIV infection: What the virus spares is as important as what it destroys. Nat. Med. 2006, 12, 289-295.
64. Mattapallil, J.J.; Douek, D.C.; Hill, B.; Nishimura, Y.; Martin, M.; Roederer, M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434, 1093-1097.
65. Guadalupe, M.; Reay, E.; Sankaran, S.; Prindiville, T.; Flamm, J.; McNeil, A.; Dandekar, S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003, 77, 11708-11717.
66. Brenchley, J.M.; Price, D.A.; Schacker, T.W.; Asher, T.E.; Silvestri, G.; Rao, S.; Kazzaz, Z.; Bornstein, E.; Lambotte, O.; Altmann, D.; et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12, 1365-1371.
67. Emu, B.; Sinclair, E.; Favre, D.; Moretto, W.J.; Hsue, P.; Hoh, R.; Martin, J.N.; Nixon, D.F.; McCune, J.M.; Deeks, S.G. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 2005, 79, 14169-14178.
68. Yin, L.; Rodriguez, C.A.; Hou, W.; Potter, O.; Caplan, M.J.; Goodenow, M.M.; Sleasman, J.W. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD27- CD11a(bright) activated T cells. J. Allergy Clin. Immunol. 2008, 122, 166-172.e2.
69. Silvestri, G.; Paiardini, M.; Pandrea, I.; Lederman, M.M.; Sodora, D.L. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 2007, 117, 3148-3154.
70. Estes, J.D.; Harris, L.D.; Klatt, N.R.; Tabb, B.; Pittaluga, S.; Paiardini, M.; Barclay, G.R.; Smedley, J.; Pung, R.; Oliveira, K.M.; et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010, 6, doi:10.1371/journal.ppat.1001052.
71. Hofer, U.; Schlaepfer, E.; Baenziger, S.; Nischang, M.; Regenass, S.; Schwendener, R.; Kempf, W.; Nadal, D.; Speck, R.F. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog. 2010, 6, doi:10.1371/journal.ppat.1000867.
72. Rempel, H.; Sun, B.; Calosing, C.; Pillai, S.K.; Pulliam, L. Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. Aids 2010, 24, 1415-1423.
73. Rajasuriar, R.; Booth, D.; Solomon, A.; Chua, K.; Spelman, T.; Gouillou, M.; Schlub, T.E.; Davenport, M.; Crowe, S.; Elliott, J.; et al. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: The role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation. J. Infect. Dis. 2010, 202, 1254-1264.
74. Piconi, S.; Trabattoni, D.; Gori, A.; Parisotto, S.; Magni, C.; Meraviglia, P.; Bandera, A.; Capetti, A.; Rizzardini, G.; Clerici, M. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. Aids 2010, 24, 1991-2000.
75. Wallet, M.A.; Rodriguez, C.A.; Yin, L.; Saporta, S.; Chinratanapisit, S.; Hou, W.; Sleasman, J.W.; Goodenow, M.M. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. Aids 2010, 24, 1281-1290.
76. Gordon, S.N.; Klatt, N.R.; Bosinger, S.E.; Brenchley, J.M.; Milush, J.M.; Engram, J.C.; Dunham, R.M.; Paiardini, M.; Klucking, S.; Danesh, A.; et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J. Immunol. 2007, 179, 3026-3034.
77. Brenchley, J.M.; Paiardini, M.; Knox, K.S.; Asher, A.I.; Cervasi, B.; Asher, T.E.; Scheinberg, P.; Price, D.A.; Hage, C.A.; Kholi, L.M.; et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112, 2826-2835.
78. Ancuta, P.; Monteiro, P.; Sekaly, R.P. Th17 lineage commitment and HIV-1 pathogenesis. Curr. Opin. HIV AIDS 2010, 5, 158-165.
79. Gaboriau-Routhiau, V.; Rakotobe, S.; Lecuyer, E.; Mulder, I.; Lan, A.; Bridonneau, C.; Rochet, V.; Pisi, A.; de Paepe, M.; Brandi, G.; et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31, 677-689.
80. Aujla, S.J.; Dubin, P.J.; Kolls, J.K. Th17 cells and mucosal host defense. Semin. Immunol. 2007, 19, 377-382.
81. Chiba, Y.; Shida, K.; Nagata, S.; Wada, M.; Bian, L.; Wang, C.; Shimizu, T.; Yamashiro, Y.; Kiyoshima-Shibata, J.; Nanno, M.; Nomoto, K. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 2010, 130, 352-362.
82. Cecchinato, V.; Trindade, C.J.; Laurence, A.; Heraud, J.M.; Brenchley, J.M.; Ferrari, M.G.; Zaffiri, L.; Tryniszewska, E.; Tsai, W.P.; Vaccari, M.; et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008, 1, 279-288.
83. Favre, D.; Lederer, S.; Kanwar, B.; Ma, Z.M.; Proll, S.; Kasakow, Z.; Mold, J.; Swainson, L.; Barbour, J.D.; Baskin, C.R.; et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 2009, 5, doi:10.1371/journal. ppat.1000295.
84. Perez-Cano, F.J.; Dong, H.; Yaqoob, P. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: Two probiotic strains isolated from human breast milk. Immunobiology 2010, 215, 996-1004.
85. Smits, H.H.; Engering, A.; van der Kleij, D.; de Jong, E.C.; Schipper, K.; van Capel, T.M.; Zaat, B.A.; Yazdanbakhsh, M.; Wierenga, E.A.; van Kooyk, Y.; et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115, 1260-1267.
86. Prendergast, A.; Prado, J.G.; Kang, Y.H.; Chen, F.; Riddell, L.A.; Luzzi, G.; Goulder, P.; Klenerman, P. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. Aids 2010, 24, 491-502.
87. Denning, T.L.; Wang, Y.C.; Patel, S.R.; Williams, I.R.; Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 2007, 8, 1086-1094.
88. Mucida, D.; Park, Y.; Kim, G.; Turovskaya, O.; Scott, I.; Kronenberg, M.; Cheroutre, H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317, 256-260.
89. Chaudhry, A.; Rudra, D.; Treuting, P.; Samstein, R.M.; Liang, Y.; Kas, A.; udensky, A.Y. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326, 986-991.
90. Elyaman, W.; Bradshaw, E.M.; Uyttenhove, C.; Dardalhon, V.; Awasthi, A.; Imitola, J.; Bettelli, E.; Oukka, M.; van Snick, J.; Renauld, J.C. et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 2009, 106, 12885-12890.
91. Lavasani, S.; Dzhambazov, B.; Nouri, M.; Fak, F.; Buske, S.; Molin, G.; Thorlacius, H.; Alenfall, J.; Jeppsson, B.; Westrom, B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010, 5, doi:10.1371/journal.pone.0009009.
92. Kwon, H.K.; Lee, C.G.; So, J.S.; Chae, C.S.; Hwang, J.S.; Sahoo, A.; Nam, J.H.; Rhee, J.H.; Hwang, K.C.; Im, S.H. Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 2010, 107, 2159-2164.
93. De Roock, S.; van Elk, M.; van Dijk, M.E.; Timmerman, H.M.; Rijkers, G.T.; Prakken, B.J.; Hoekstra, M.O.; de Kleer, I.M. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin. Exp. Allergy 2010, 40, 103-110.
94. Wolf, B.W.; Wheeler, K.B.; Ataya, D.G.; Garleb, K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 1998, 36, 1085-1094.
95. Nugent, R.P.; Krohn, M.A.; Hillier, S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991, 29, 297-301.
96. Cu-Uvin, S.; Hogan, J.W.; Caliendo, A.M.; Harwell, J.; Mayer, K.H.; Carpenter, C.C. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin. Infect. Dis. 2001, 33, 894-896.
97. Sha, B.E.; Zariffard, M.R.; Wang, Q.J.; Chen, H.Y.; Bremer, J.; Cohen, M.H.; Spear, G.T. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 2005, 191, 25-32.
98. Spear, G.T.; Gilbert, D.; Sikaroodi, M.; Doyle, L.; Green, L.; Gillevet, P.M.; Landay, A.L.; Veazey, R.S. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: Implications for use as an animal model for HIV vaginal infection. AIDS Res. Hum. Retrovir. 2010, 26, 193-200.
99. Mitchell, C.; Moreira, C.; Fredricks, D.; Paul, K.; Caliendo, A.M.; Kurpewski, J.; Ingersoll, J.; Cu-Uvin, S. Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 2009, 2009, doi:10.1155/2009/236919.
100. Farquhar, C.; Mbori-Ngacha, D.; Overbaugh, J.; Wamalwa, D.; Harris, J.; Bosire, R.; John-Stewart, G. Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission. Aids 2010, 24, 153-155.
101. Anukam, K.C.; Osazuwa, E.; Osemene, G.I.; Ehigiagbe, F.; Bruce, A.W.; Reid, G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006, 8, 2772-2776.
102. Senok, A.C.; Verstraelen, H.; Temmerman, M.; Botta, G.A. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst. Rev. 2009, doi:10.1002/14651858.CD006289.pub2.
103. Parent, D.; Bossens, M.; Bayot, D.; Kirkpatrick, C.; Graf, F.; Wilkinson, F.E.; Kaiser, R.R. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: A placebo-controlled multicentric clinical trial. Arzneimittelforschung 1996, 46, 68-73.
104. Anukam, K.; Osazuwa, E.; Ahonkhai, I.; Ngwu, M.; Osemene, G.; Bruce, A.W.; Reid, G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect. 2006, 8, 1450-1454.
105. Gonçalves, L.S.; Ferreira, S.M.; Silva, A., Jr.; Villoria, G.E.; Costinha, L.H.; Souto, R.; Uzeda, M.D.; Colombo, A.P. Association of T CD4 lymphocyte levels and subgingival microbiota of chronic periodontitis in HIV-infected Brazilians under HAART. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2004, 97, 196-203.
106. Aas, J.A.; Barbuto, S.M.; Alpagot, T.; Olsen, I.; Dewhirst, F.E.; Paster, B.J. Subgingival plaque microbiota in HIV positive patients. J. Clin. Periodontol. 2007, 34, 189-195.
107. Tsang, C.S.; Samaranayake, L.P. Predominant cultivable subgingival microbiota of healthy and HIV-infected ethnic Chinese. APMIS 2001, 109, 117-126.
108. Murray, P.A.; Grassi, M.; Winkler, J.R. The microbiology of HIV-associated periodontal lesions. J. Clin. Periodontol. 1989, 16, 636-642.
109. Silva-Boghossian, C.; Castro, G.F.; Teles, R.P.; de Souza, I.P.; Colombo, A.P. Salivary microbiota of HIV-positive children and its correlation with HIV status, oral diseases, and total secretory IgA. Int. J. Paediatr. Dent. 2008, 18, 205-216.
110. Anukam, K.C.; Osazuwa, E.O.; Osadolor, H.B.; Bruce, A.W.; Reid, G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J. Clin. Gastroenterol. 2008, 42, 239-243.
111. Reid, G.; Anand, S.; Bingham, M.O.; Mbugua, G.; Wadstrom, T.; Fuller, R.; Anukam, K.; Katsivo, M. Probiotics for the developing world. J. Clin. Gastroenterol. 2005, 39, 485-488.
112. Resta-Lenert, S.; Barrett, K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52, 988-997.
113. Resta-Lenert, S.C.; Barrett, K.E. Modulation of intestinal barrier properties by probiotics: Role in reversing colitis. Ann. N. Y. Acad. Sci. 2009, 1165, 175-182.
114. Guarino, A.; Canani, R.B.; Spagnuolo, M.I.; Albano, F.; Di Benedetto, L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 1997, 25, 516-519.
115. Miettinen, M.; Vuopio-Varkila, J.; Varkila, K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 1996, 64, 5403-5405.
116. Salminen, M.K.; Tynkkynen, S.; Rautelin, H.; Poussa, T.; Saxelin, M.; Ristola, M.; Valtonen, V.; Jarvinen, A. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: A randomized, placebo-controlled, crossover study. HIV Clin. Trials 2004, 5, 183-191.
117. Kerac, M.; Bunn, J.; Seal, A.; Thindwa, M.; Tomkins, A.; Sadler, K.; Bahwere, P.; Collins, S. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): A double-blind efficacy randomised controlled trial in Malawi. Lancet 2009, 374, 136-144.
118. Trois, L.; Cardoso, E.M.; Miura, E. Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J. Trop. Pediatr. 2008, 54, 19-24.
119. Monachese, M.; Cunningham-Rundles, S.; Diaz, M.A.; Guerrant, R.; Hummelen, R.; Kemperman, R.; Kerac, M.; Kort, R.; Merenstein, D.J.; Panigrahi, P.; et al. Probiotics and prebiotics to combat enteric infections and HIV in the developing world: A consensus report. Gut Microbes 2011, 2, 198-207.
120. Black, R.E.; Morris, S.S.; Bryce, J. Where and why are 10 million children dying every year? Lancet 2003, 361, 2226-2234.
121. Grantham-McGregor, S.; Cheung, Y.B.; Cueto, S.; Glewwe, P.; Richter, L.; Strupp, B. Developmental potential in the first 5 years for children in developing countries. Lancet 2007, 369, 60-70.
122. Moye, J., Jr.; Rich, K.C.; Kalish, L.A.; Sheon, A.R.; Diaz, C.; Cooper, E.R.; Pitt, J.; Handelsman, E. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J. Pediatr. 1996, 128, 58-69.
123. Cunningham-Rundles, S.; Ahrn, S.; Abuav-Nussbaum, R.; Dnistrian, A. Development of immunocompetence: Role of micronutrients and microorganisms. Nutr. Rev. 2002, 60, S68-S72.
124. Taha, T.E.; Dallabetta, G.A.; Canner, J.K.; Chiphangwi, J.D.; Liomba, G.; Hoover, D.R.; Miotti, P.G. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int. J. Epidemiol. 1995, 24, 1022-1029.
125. Filteau, S.; Baisley, K.; Chisenga, M.; Kasonka, L.; Gibson, R.S. Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed, uninfected Zambian children to catch up in growth to HIV-unexposed children: A randomised controlled trial. J. Acquir. Immune Defic. Syndr. 2011, 56, 166-175.
126. Nielsen, S.; Nielsen, D.S.; Lauritzen, L.; Jakobsen, M.; Michaelsen, K.F. Impact of diet on the intestinal microbiota in 10-month-old infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44, 613-618.
127. Iwata, M.; Hirakiyama, A.; Eshima, Y.; Kagechika, H.; Kato, C.; Song, S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21, 527-538.
128. Mora, J.R.; Iwata, M.; Eksteen, B.; Song, S.Y.; Junt, T.; Senman, B.; Otipoby, K.L.; Yokota, A.; Takeuchi, H.; Ricciardi-Castagnoli, P.; et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314, 1157-1160.
129. Cunningham-Rundles, S.; Lin, H.; Ho-Lin, D.; Dnistrian, A.; Cassileth, B.R.; Perlman, J.M. Role of nutrients in the development of neonatal immune response. Nutr. Rev. 2009, 67 (Suppl. 2), S152-S163.
130. Steenhout, P.G.; Rochat, F.; Hager, C. The effect of Bifidobacterium lactis on the growth of infants: A pooled analysis of randomized controlled studies. Ann. Nutr. Metab. 2009, 55, 334-340.
131. Taye, B.; Shiferaw, S.; Enquselassie, F. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop. Med. J. 2010, 48, 1-10.
132. Miller, T.L.; Mawn, B.E.; Orav, E.J.; Wilk, D.; Weinberg, G.A.; Nicchitta, J.; Furuta, L.; Cutroni, R.; McIntosh, K.; Burchett, S.K.; et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 2001, 107, doi:10.1542/peds.107.5.e77.
133. Weigel, R.; Phiri, S.; Chiputula, F.; Gumulira, J.; Brinkhof, M.; Gsponer, T.; Tweya, H.; Egger, M.; Keiser, O. Growth response to antiretroviral treatment in HIV-infected children: A cohort study from Lilongwe, Malawi. Trop. Med. Int. Health 2010, 15, 934-944.
134. Chantry, C.J.; Frederick, M.M.; Meyer, W.A., III; Handelsman, E.; Rich, K.; Paul, M.E.; Diaz, C.; Cooper, E.R.; Foca, M.; Adeniyi-Jones, S.K.; et al. Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 2007, 26, 53-60.
135. Chantry, C.J.; Hughes, M.D.; Alvero, C.; Cervia, J.S.; Hodge, J.; Borum,
136. Lochner, M.; Ohnmacht, C.; Presley, L.; Bruhns, P.; Si-Tahar, M.; Sawa, S.; Eberl, G. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J. Exp. Med. 2011, 208, 125-134.
137. Newell, M.L.; Borja, M.C.; Peckham, C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 2003, 111, e52-e60.
138. Pediatric HIV Surveillance (through 2009). Available online: http://www.cdc.gov/hiv/graphics/pediatri.htm (accessed on 15 October 2011).
139. Miller, T.L.; Easley, K.A.; Zhang, W.; Orav, E.J.; Bier, D.M.; Luder, E.; Ting, A.; Shearer, W.T.; Vargas, J.H.; Lipshultz, S.E. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: The prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics 2001, 108, 1287-1296.
140. Carey, V.J.; Yong, F.H.; Frenkel, L.M.; McKinney, R.M. Growth velocity assessment in paediatric AIDS: Smoothing, penalized quantile regression and the definition of growth failure. Stat. Med. 2004, 23, 509-526.
141. Cunningham-Rundles, S.; Ahrne, S.; Peoples, J.; Tatad, F.; Mohamed, M.; Nesin, M. Role of Probiotics in the Modulation of Host Immune Response. In Ending the War Metaphor: The Changing Agenda for Unravellng the Host Microbe Relationships Institute of Medicine; National Academy Press: Washington, DC, USA, 2006; pp. 220-229.
142. Cunningham-Rundles, S.; Nesin, M. Bacterial Infections in the Immunologically Compromised Host. In Persistent Bacterial Infections; Nataro, J., Blaser, M., Cunningham-Rundles, S., Eds.; American Society of Microbiology Press: Washington, DC, USA, 2000; pp. 145-164.
143. Merlini, E.; Bai, F.; Bellistri, G.M.; Tincati, C.; d'Arminio Monforte, A.; Marchetti, G. Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One 2011, 6, doi:10.1371/journal.pone.0018580.